SciBase Nevisense detects age-related skin changes
Analysis based on 9 articles · First reported May 18, 2026 · Last updated May 18, 2026
The announcement of expanded applications for Nevisense>>> technology by SciBase>>> is likely to positively impact its stock price, as evidenced by the initial 3.37% increase. This development opens new market segments in geriatric dermatology and longevity science, potentially increasing SciBase>>>'s revenue streams and market valuation.
SciBase Holding AB announced new research findings at the Society for Investigative Dermatology Annual Meeting, highlighting the expanded potential of its Nevisense platform. The study, conducted by prof. Abuabara and Dr. Zhu at the University of California, San Francisco, demonstrated that SciBase's Electrical impedance spectroscopy (EIS) technology can successfully detect and quantify age-related changes in the skin barrier. This research expands Nevisense's application beyond melanoma detection and atopic dermatitis into geriatric dermatology and longevity science. The study identified 35 age-associated EIS features and developed a composite barrier score strongly correlated with age, indicating Nevisense's ability to detect subtle changes in skin architecture. Pia Renaudin, CEO of SciBase, emphasized the significance of these results for clinical dermatology and targeted skincare development. SciBase plans further validation to refine the composite barrier score for clinical and research use. SciBase's stock (SCIB.ST) saw an initial increase of 3.37% following the announcement.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard